Canaccord Starts ANI Pharmaceuticals (ANIP) at Hold
Canaccord analyst Gary Newman initiates coverage on ANI Pharmaceuticals (NASDAQ: ANIP) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
